OPTIMA Oncology shared a post on LinkedIn:
“ESMO25 we are coming!
OPTIMA will be strongly represented at ‘The ESMO AI and Digital Oncology Congress 2025’ in Berlin, 12-14 November.
GREAT NEWS: OPTIMA will be present at the POSTER LUNCH!
The submitted abstract was successfully accepted. ‘211P – OPTIMA: European real-world oncology data and evidence generation platform for improving oncology care in prostate, lung, and breast cancer’.
When? -> Wednesday 12th November, 14:45 – 15:45
Who? -> Poster presented by Nadezhda Knauer, MD, PhD of BDM Consulting
Curious what it will be about?
-> FIND HERE A SUMMARY OF THE SUBMITTED ABSTRACT
OPTIMA is a European initiative that brings together leading experts and organizations to develop an interoperable, GDPR-compliant platform integrating AI and real-world data for breast, lung, and prostate cancer. By aggregating data from millions of patients across European registries, the platform provides actionable AI-driven insights and guideline-based decision support tools to enhance patient-centric care and clinical knowledge.
Early analyses have revealed significant variations in treatment pathways, highlighting OPTIMA’s capability to generate robust real-world evidence and drive innovation in oncology practice and beyond.
OPTIMA Oncology – Tackling cancer through real world data and artificial intelligence.”
More posts featuring ESMO on OncoDaily.